Andréa Capra

Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project

Mattia D’Agostino, David A. Cairns, Juan José Lahuerta et al. · Journal of Clinical Oncology · 2022 · 407 citations · Full text

Medicine, Oncology, Molecular Oncology +15

High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma

Luca Bertamini, Stefania Oliva, Delia Rota‐Scalabrini et al. · Journal of Clinical Oncology · 2022 · 88 citations · Full text

Medicine, Hematology, Oncology +17

Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial

Roberto Mina, Pellegrino Musto, Delia Rota‐Scalabrini et al. · The Lancet Oncology · 2022 · 85 citations · Full text

Medicine, Hematology, Oncology +17

Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma

Alessandra Larocca, Francesca Bonello, Gianluca Gaïdano et al. · Blood · 2021 · 81 citations · Full text

Medicine, Geriatric Medicine, Oncology +12

Mammographic Density and Breast Cancer After Ductal Carcinoma In Situ

Laurel A. Habel, James J. Dignam, S. R. Land et al. · JNCI Journal of the National Cancer Institute · 2004 · 71 citations · Full text

Medicine, Oncology, Radiology +17